Audio

Mark Freedman, MD

Publish date: July 24, 2013

The Promise of Mesenchymal Stem Cells for Patients With MS

 

Recommended Reading

New and Noteworthy Information—May 2013
ICYMI Multiple Sclerosis
PEGylated Interferon Beta-1a May Reduce Annualized Relapse Rate in Patients With MS
ICYMI Multiple Sclerosis
Stuart Cook, MD, Discusses the CMSC Joint Statement on Adding MRI to the Lublin–Reingold Classification of MS
ICYMI Multiple Sclerosis
Could Stem Cells Reduce Inflammatory Lesions in Patients With MS?
ICYMI Multiple Sclerosis
How Prevalent Is Pain in MS?
ICYMI Multiple Sclerosis
Tool May Identify Risk of Transition to Secondary Progressive MS
ICYMI Multiple Sclerosis
News Briefs From the Fifth Cooperative Meeting of CMSC/ACTRIMS
ICYMI Multiple Sclerosis
Anti-JCV Antibody Index May Further Define PML Risk
ICYMI Multiple Sclerosis
Fingolimod Slows MS Brain Atrophy Within Six Months
ICYMI Multiple Sclerosis
Simvastatin May Reduce Brain Atrophy in Patients With Secondary Progressive MS
ICYMI Multiple Sclerosis

Related Articles